Targeting cancer stem cells: a new therapy to cure cancer patients.
Authors:
- 28 April 2012
- journal article
- Vol. 2 (3) , 340-56
Abstract
Cancer stem cells (CSCs) have been defined as cells within tumor that possess the capacity to self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumor. They have been identified in blood, breast, brain, colon, melanoma, pancreatic, prostate, ovarian, lung cancers and so on. It is often considered to be associated with chemo-resistance and radio-resistance that lead to the failure of traditional therapies. Most therapies are directed at the fast growing tumor mass but not the slow dividing cancer stem cells. Eradicating cancer stem cells, the root of cancer origin and recurrence, has been thought as a promising approach to improve cancer survival or even to cure cancer patients. Understanding the characteristics of cancer stem cells will help to develop novel therapies to eliminate the initiating cancer stem cell, and the relevant patents on the cancer stem cell and cancer therapy by cancer stem cells will be discussed.Keywords
This publication has 100 references indexed in Scilit:
- Notch signaling: Emerging molecular targets for cancer therapyBiochemical Pharmacology, 2010
- Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: Towards targeting of cancer stem cells with phytochemicalsCancer Letters, 2010
- Targeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Research and Treatment, 2009
- CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cellsInternational Journal of Cancer, 2009
- CD133+ liver cancer stem cells from methionine adenosyl transferase 1A–deficient mice demonstrate resistance to transforming growth factor (TGF)-β–induced apoptosis #Hepatology, 2009
- Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signatureClinical & Experimental Metastasis, 2009
- Cancer Stem Cell–Directed Therapies: Recent Data From the Laboratory and ClinicMolecular Therapy, 2009
- Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In VivoCancer Cell, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Mutations affecting segment number and polarity in DrosophilaNature, 1980